2 results
Approved WMOWill not start
To evaluate the efficacy, safety and PK of solifenacin succinate suspension after multiple dose administration.
Approved WMORecruiting
* To decrease mortality in MS-LCH by an early switch of patients with risk organ involvement, who do not respond to front-line therapy, to a more intensive treatment (Stratum III or Stratum IV).* To reduce reactivation rates and permanent…